SCHEMBL5771657

SCHEMBL5771657

Cc1nc(-c2nccs2)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.45
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
MAT2A P31153 1/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
KDR P35968 2/20 0.38
HSD17B10 Q99714 1/20 0.38
CDC7 O00311 1/20 0.36
CYP2A6 P11509 1/20 0.35
COMT P21964 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774277 0.80 MAPT (0.46) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5772983 0.79 KDM4E (0.49) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5777535 0.77 NPY5R (0.51) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5776173 0.75 NPY5R (0.51) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5775603 0.75 ADORA3 (0.50) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5772874 0.74 KDM4E (0.47) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5772797 0.73 ADORA3 (0.41) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5796755 0.73 ADORA3 (0.43) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5771758 0.73 ADORA2A (0.48) ADORA3ADORA2AADORA1KDM4EHPGD
SCHEMBL5774543 0.73 ADORA1 (0.48) ADORA3ADORA2AADORA1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP claimed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US claimed
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed